Human Immunodeficiency Virus Persistence and T-Cell Activation in Blood, Rectal, and Lymph Node Tissue in Human Immunodeficiency Virus–Infected Individuals Receiving Suppressive Antiretroviral Therapy
Gabriela Khoury(Burnet Institute), Sharon R. Lewin(Peter Doherty Institute), Rémi Fromentin(Centre Hospitalier de l’Université de Montréal), Rebecca Hoh(University of California, San Francisco), Wendy Hartogensis(University of California, San Francisco), Frederick Hecht(University of California, San Francisco), Jenny L. Anderson(The Royal Melbourne Hospital), Paul Cameron(The Royal Melbourne Hospital), Valerie Girling, Peter Bacchetti(University of California, San Francisco), Steven G. Deeks(University of California, San Francisco), Nicolas Chomont(Vaccine & Gene Therapy Institute of Florida), Peter W. Hunt(University of California, San Francisco), Marisela Killian(University of California, San Francisco), Elizabeth Sinclair(San Francisco General Hospital), Ajantha Solomon(The Royal Melbourne Hospital), Ma Somsouk(University of California, San Francisco)
Cited by 106
Related Papers
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
|Nature Medicine|2006|3.6k
Liver Transplantation for Hepatocellular Carcinoma: Expansion of the Tumor Size Limits Does Not Adversely Impact Survival
|Hepatology|2001|2.3k
HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation
|Nature Medicine|2009|1.7k
Plasma Levels of Soluble CD14 Independently Predict Mortality in HIV Infection
|The Journal of Infectious Diseases|2011|1.1k
Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival
|New England Journal of Medicine|2009|1.1k